National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01XX24	ONCASPAR	B	Pegaspargase - 750U/ml	750U/ml	Injectable powder for solution	L.L
L01EX09	OFEV	B	Nintedanib - 100mg	100mg	Capsule, soft	104,970,726 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	209,943,871 L.L
A03AX13	OVOL	B	Simethicone - 40mg/ml	40mg/ml	Drops	233,829 L.L
L04AA32	OTEZLA	B	Apremilast - 4x10mg- 4x20mg- 19x30mg		Tablet, film coated	34,751,325 L.L
A03AX13	OVOL FOR GAZ	B	Simethicone - 180mg	180mg	Capsule, liquid gel	241,892 L.L
J01XA05	ORBACTIV	B	Oritavancin (diphosphate) - 400mg	400mg	Injectable powder for concentrate for solution + solvent	157,078,205 L.L
L04AA32	OTEZLA	B	Apremilast - 30mg	30mg	Tablet, film coated	49,829,454 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
H01CC01	ORGALUTRAN	B	Ganirelix - 0.25mg/0.5ml	0.25mg/0.5ml	Injectable solution	2,383,977 L.L
R03AC18	ONBREZ BREEZHALER	B	Indacaterol maleate - 150mcg	150mcg	Capsule, inhalation	2,284,532 L.L
L04AA37	OLUMIANT	B	Baricitinib - 2mg	2mg	Tablet, film coated	68,053,864 L.L
L04AA37	OLUMIANT	B	Baricitinib - 4mg	4mg	Tablet, film coated	68,053,864 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l		Injectable emulsion	4,711,512 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
N05AG02	ORAP FORTE	B	Pimozide - 4mg	4mg	Tablet	329,241 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
C02KX04	OPSUMIT	B	Macitentan - 10mg	10mg	Tablet, film coated	L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	2,025,171 L.L
J01DD15	OMNICEF	B	Cefdinir - 125mg/5ml	125mg/5ml	Powder for suspension	1,189,301 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
J01DD15	OMNICEF	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
J01DD15	OMNICEF 300	B	Cefdinir - 300mg	300mg	Capsule	2,238,842 L.L
J01DD15	OMNICEF	B	Cefdinir - 250mg/5ml	250mg/5ml	Powder for suspension	3,670,034 L.L
A05AA04	OCALIVA	B	Obeticholic acid - 10mg	10mg	Tablet, film coated	224,503,943 L.L

...